Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Holy Basil and Phosphatidylserine are closely matched across evidence, studies, and safety.
Verdict
Mostly mechanism / observational
0 of 1 studies with measurable effects showed benefit.
Top outcomes
Verdict
Mostly mechanism / observational
1 of 1 studies with measurable effects showed benefit.
Top outcomes
300-600mg extract (2.5% ursolic acid)
Morning, With or without food
Standardized extract (leaf)
100-300mg daily
With meals, Evening or post-workout for cortisol
Soy or sunflower-derived phosphatidylserine
2-4 weeks
2-4 weeks
4-8 weeks
4-12 weeks
2 weeks
4-8 weeks
The Neuroprotective Potential of Ocimum Plant Species: Seasoning the Mind with Sweet and Holy Basil
Nutrients (2025) · Systematic review
This review synthesizes experimental evidence regarding Ocimum species with neuroprotective potential in AD, particularly Ocimum sanctum and Ocimum basilicum.
Modulation of the hypothalamic-pituitary-adrenal (HPA) axis by plants and phytonutrients: a systematic review of human trials
Nutritional neuroscience (2022) · Systematic review
For most phytonutrients, the effects of supplementation on HPA-axis activity in humans is unclear.
Medicinal Plants in the Treatment of Respiratory Diseases and their Future Aspects
Recent patents on biotechnology (2025) · Systematic review
Some medicinal plants, notably Echinacea purpurea and Zingiber officinale, exhibit potential for adjuvant symptomatic therapy in respiratory conditions, such as chronic obstructive pulmonary disease (COPD), bronchitis, asthma, the common cold, cough, and whooping cough.
Effects of a food supplement containing phosphatidylserine on cognitive function in Chinese older adults with mild cognitive impairment: A randomized double-blind, placebo-controlled trial
Journal of affective disorders (2025) · Rct · n=190
A total of 190 participants (mean [SD] age, 67.95 [5.62] years; 70 (36.8 %) male and 120 (63.2 %) female) were randomized to the placebo group (n = 95) and intervention group (n = 95).
Phosphatidylserine containing omega-3 fatty acids may improve memory abilities in non-demented elderly with memory complaints: a double-blind placebo-controlled trial
Dementia and geriatric cognitive disorders (2010) · Rct · n=157
157 participants were randomized to receive either PS-DHA or placebo for 15 weeks.
Phosphatidylserine for the Treatment of Pediatric Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis
Journal of alternative and complementary medicine (2021) · Meta analysis · n=216
Four studies met the inclusion criteria for the narrative review (n = 344) and three for the meta-analysis (n = 216).
Based on systematic review evidence of HPA-axis modulation and adaptogenic properties. However, reviewers note that effects on HPA-axis activity in humans remain unclear and require more definitive research. Conservative estimates due to limited human trial data.
Based on RCT in 190 Chinese older adults with mild cognitive impairment and systematic review of neuronutrients. Limited by small number of direct studies and population-specific findings.
AI-estimated from published studies. Interpret as directional guidance.
Both Holy Basil and Phosphatidylserine are closely matched — the best choice depends on your specific health goals.
For build stress resilience, Holy Basil has a higher relevance score (85 vs 72).
No known interactions between Holy Basil and Phosphatidylserine have been documented in our database. However, always consult a healthcare provider before combining supplements.